Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...
The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.
As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...
Opinion
Editorial Roundup: United States
The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling an expor ...
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...